durvalumab
astrazeneca,orpathys
['calypso', 'biomarker']
calypso: ambitious study with interesting findings indeed. controversy about the role of met and other biomarkers in this setting. #asco22 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid